First-of-its-kind rapid autopsy program helps reveal deadly disease’s potential vulnerabilities
June 11, 2019
| By Sabrina Richards / Fred Hutch News Service
"In order to target metastatic disease, we need to understand it. In order to understand it, we need to be able to study it, and in order to study it, we need to have access to these precious and rare tissues,” said Dr. Andrew Hsieh.
As an eligibility barrier cracks, a lung cancer patient gets a new lease on life
June 7, 2019
| By Fred Hutch News Service staff
A new study led by physicians at Fred Hutchinson Cancer Research Center shows that patients with HIV and one of a variety of potentially deadly cancers can be safely treated with the immunotherapy drug pembrolizumab, also known by its brand name, KEYTRUDA®.
Fred Hutch scientists used their new golden courier to edit genes tied to HIV, genetic blood disorders
May 27, 2019
| By Jake Siegel / Fred Hutch News Service
Forget UPS and FedEx: Tiny golden delivery trucks created at Fred Hutch can ship CRISPR into human blood stem cells, offering a potential way to treat diseases like HIV and sickle cell anemia in patients around the world.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.